Regarding pharmaceutical expenditure:

— Can the Commission say what general information it has regarding this matter and in particular regarding pharmaceutical expenditure by insurance funds for the years 2009, 2010, 2011 and 2012?
— How are annual pharmaceutical expenditure targets set under the financial assistance programme for Greece?
— What is the Commission’s role within the Troika regarding pharmaceutical expenditure, particularly for the purposes of combating unnecessary drugs prescription?